Your browser doesn't support javascript.
loading
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor.
Zeng, L; Zielinska, H A; Arshad, A; Shield, J P; Bahl, A; Holly, J M P; Perks, C M.
Affiliation
  • Zeng L; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Zielinska HA; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Arshad A; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Shield JP; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Bahl A; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Holly JM; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK.
  • Perks CM; IGFs and Metabolic Endocrinology GroupSchool of Clinical Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol BS10 1TD, UKDepartment of Clinical OncologyBristol Haematology and Oncology Centre, University Hospitals Bristol, Bristol, UK claire.m.perks@bristol.a
Endocr Relat Cancer ; 23(2): 125-34, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26647383
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Drug Resistance, Neoplasm / Estrogen Receptor alpha / Hyperglycemia Limits: Female / Humans Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Drug Resistance, Neoplasm / Estrogen Receptor alpha / Hyperglycemia Limits: Female / Humans Language: En Journal: Endocr Relat Cancer Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom